Bellevue Asia Pacific Healthcare I2 CHF

Dati di base

ISIN LU1587985067
Numero di valore
Bloomberg Global ID
Nome del fondo Bellevue Asia Pacific Healthcare I2 CHF
Offerente del fondo Bellevue Asset Management AG Zürich, Svizzera
Telefono: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Offerente del fondo Bellevue Asset Management AG
Rappresentante in Svizzera Waystone Fund Services (Switzerland) SA
Lausanne
Telefono: 0041213111781
Distributore(i) Bank am Bellevue AG
Küsnacht
Telefono: +41 44 267 67 67
Asset class Fondi azionari
EFC Categoria
Classe di quote Accumulation
Paese di domicilio Lussemburgo
Condizioni all-unknown-emissione Combinazione di commissione di emissione a favore della direzione del fondo e commissione di transazione a favore del fondo
Condizioni al riscatto Combinazione di commissione di riscatto a favore della direzione del fondo e commissione di transazione a favore del fondo
Strategia d'investimenti *** The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies that have their registered office or carry out the majority of their economic activity in the healthcare markets of the Asia-Pacific region. The universe for companies is determined cumulatively as follows:  Shares of companies that have their registered office or carry out the majority of their economic activity in the healthcare sector in the Asia-Pacific region. These include companies operating in such areas as generics, medtech, biotech, pharma and health services which are involved in the development, manufacture or sale of products and services. Listed on a recognised stock market or, in the case of an initial public offering, the company has applied for listing on the relevant exchange.
Particolarità

Prezzi del fondo

Prezzo attuale * 140.79 CHF 04.07.2024
Prezzo precedente * 140.79 CHF 03.07.2024
Max 52 settimani * 157.06 CHF 01.08.2023
Min 52 settimani * 136.27 CHF 19.04.2024
NAV * 140.79 CHF 04.07.2024
Issue Price *
Redemption Price *
Closing Price *
Prezzo minimo indicativo
Attivo del fondo *** 118'118'069
Attivo della classe ***
Trading Information SIX

Performance

Performance YTD -1.32% 29.12.2023
04.07.2024
1 mese +0.68% 04.06.2024
04.07.2024
3 mesi -2.78% 04.04.2024
04.07.2024
6 mesi -0.60% 04.01.2024
04.07.2024
1 anno -9.17% 04.07.2023
04.07.2024
2 anni -24.57% 04.07.2022
04.07.2024
3 anni -48.31% 05.07.2021
04.07.2024
5 anni -47.20% 15.06.2021
04.07.2024

Dati fiscali

Quota di partecipazione al capitale in %
Utile totale del fondo in %
Quota immobiliare in %
ADDI
ADDI Date

10 posizioni principali ***

Daiichi Sankyo Co Ltd 9.75%
Otsuka Holdings Co Ltd 6.42%
CSL Ltd 5.61%
Legend Biotech Corp ADR 5.33%
Terumo Corp 4.41%
Takeda Pharmaceutical Co Ltd 4.34%
Samsung BioLogics Co Ltd 4.30%
Olympus Corp 4.09%
Eisai Co Ltd 3.51%
Innovent Biologics Inc 3.36%
Ultimo aggiornamento dei dati 31.05.2024

Costi / Rischi

TER 1.52%
Data TER 29.01.2021
Performance Fee *** 0.00%
PTR
Max. Management Fee *** 0.90%
Ongoing Charges *** 1.48%
SRRI ***
Data SRRI *** 30.06.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price commissioni escluse, per fondi quotati in borsa NAV o quotazione di chiusura
** La calculazione del utile intermedio era fatto via § 9 Satz 2 InvStG
*** Sorgente dati: Morningstar (I dati si basano sulla posizione lunga riscalata delle partecipazioni)